Risk haplotypes have been identified for human non-Hodgkin’s lymphoma at HLA-A, -B, and -C, and lower expression levels of HLA-G have been associated with aggressive lymphoma and poor prognosis [73,74,75]. This evidence concerns the gene HLA-A and non-Hodgkin lymphoma.